10/7/2026
High cost of GLP-1s drives some to seek cheaper, unregulated versions
Filed by Dirk Danger
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.
D
Dirk Danger
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via PBS NewsHour · PBS NewsHour
